Eli Lilly
LLY
LLY
1,243 hedge funds and large institutions have $69.4B invested in Eli Lilly in 2017 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 417 increasing their positions, 496 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
8% less funds holding in top 10
Funds holding in top 10: 26 → 24 (-2)
16% less repeat investments, than reductions
Existing positions increased: 417 | Existing positions reduced: 496
29% less call options, than puts
Call options by funds: $371M | Put options by funds: $524M
Holders
1,243
Holding in Top 10
24
Calls
$371M
Puts
$524M
Top Buyers
| 1 | +$759M | |
| 2 | +$491M | |
| 3 | +$223M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$133M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
+$130M |
Top Sellers
| 1 | -$219M | |
| 2 | -$162M | |
| 3 | -$155M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$134M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$133M |